ARMP
Price
$2.85
Change
-$0.12 (-4.04%)
Updated
Sep 5 closing price
Capitalization
103.26M
67 days until earnings call
NRXS
Price
$2.43
Change
-$0.03 (-1.22%)
Updated
Sep 5 closing price
Capitalization
23.99M
79 days until earnings call
Interact to see
Advertisement

ARMP vs NRXS

Header iconARMP vs NRXS Comparison
Open Charts ARMP vs NRXSBanner chart's image
Armata Pharmaceuticals
Price$2.85
Change-$0.12 (-4.04%)
Volume$8.74K
Capitalization103.26M
Neuraxis
Price$2.43
Change-$0.03 (-1.22%)
Volume$16.61K
Capitalization23.99M
ARMP vs NRXS Comparison Chart in %
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. NRXS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Hold and NRXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ARMP: $2.85 vs. NRXS: $2.43)
Brand notoriety: ARMP and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 66% vs. NRXS: 25%
Market capitalization -- ARMP: $103.26M vs. NRXS: $23.99M
ARMP [@Biotechnology] is valued at $103.26M. NRXS’s [@Biotechnology] market capitalization is $23.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXS is a better buy in the long-term than ARMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 4 TA indicator(s) are bullish while NRXS’s TA Score has 3 bullish TA indicator(s).

  • ARMP’s TA Score: 4 bullish, 4 bearish.
  • NRXS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARMP is a better buy in the short-term than NRXS.

Price Growth

ARMP (@Biotechnology) experienced а +14.00% price change this week, while NRXS (@Biotechnology) price change was -4.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ARMP is expected to report earnings on Nov 12, 2025.

NRXS is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARMP($103M) has a higher market cap than NRXS($24M). ARMP YTD gains are higher at: 54.054 vs. NRXS (3.404). NRXS has higher annual earnings (EBITDA): -7.01M vs. ARMP (-10.66M). NRXS has more cash in the bank: 5.99M vs. ARMP (4.33M). NRXS has less debt than ARMP: NRXS (410K) vs ARMP (144M). NRXS has higher revenues than ARMP: NRXS (3.22M) vs ARMP (0).
ARMPNRXSARMP / NRXS
Capitalization103M24M429%
EBITDA-10.66M-7.01M152%
Gain YTD54.0543.4041,588%
P/E RatioN/AN/A-
Revenue03.22M-
Total Cash4.33M5.99M72%
Total Debt144M410K35,122%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPNRXS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLSNY7.600.08
+1.06%
Telia Company AB
PEFDF0.53N/A
N/A
DELFI LTD
ZNKKY11.39N/A
N/A
Zenkoku Hosho Co Ltd
VLAI0.30N/A
N/A
Vulcain Corporation
PVTRF1.02N/A
N/A
PIVOTREE INC. New

ARMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARMP has been loosely correlated with PTIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMP jumps, then PTIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-4.04%
PTIX - ARMP
43%
Loosely correlated
+1.61%
NRXS - ARMP
38%
Loosely correlated
-1.30%
TNGX - ARMP
31%
Poorly correlated
+1.61%
BOLT - ARMP
28%
Poorly correlated
+7.23%
FGHQF - ARMP
25%
Poorly correlated
N/A
More

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-1.30%
CVM - NRXS
59%
Loosely correlated
-6.67%
PTIX - NRXS
45%
Loosely correlated
+1.61%
ARMP - NRXS
38%
Loosely correlated
-4.04%
THRD - NRXS
33%
Loosely correlated
N/A
TNGX - NRXS
29%
Poorly correlated
+1.61%
More